Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Medical Monitoring : Continuous evaluation of your progress and safety
adults will qualify as obese by 2030 and nearly 25% as severely obese.i GLP-1s should be a key tool in managing obesity outcomes and costs: Despite higher prescription costs relative to nonusers, persistent GLP-1 use can decrease average annual total cost of care by $14K-$15K (14%) among chronically obese patients in the first one to two years of use
Shipping is domestic from within Canada, so there are no customs delays or border holds
Contrave is not a GLP-1 medication
US$ 25.27
US$ 27.98
US$ 29.43
US$ 24.02
US$ 20.25
US$ 21.30
US$ 22.66
US$ 26.56
